0001127602-24-018155.txt : 20240607 0001127602-24-018155.hdr.sgml : 20240607 20240607161238 ACCESSION NUMBER: 0001127602-24-018155 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mellion Michelle L CENTRAL INDEX KEY: 0001923040 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41374 FILM NUMBER: 241029517 MAIL ADDRESS: STREET 1: PEPGEN INC. STREET 2: 245 MAIN ST. CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PepGen Inc. CENTRAL INDEX KEY: 0001835597 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 MARINA PARK DRIVE, SUITE 900 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 703-456-8000 MAIL ADDRESS: STREET 1: 1 MARINA PARK DRIVE, SUITE 900 CITY: BOSTON STATE: MA ZIP: 02210 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-06-05 0001835597 PepGen Inc. PEPG 0001923040 Mellion Michelle L 321 HARRISON AVE., 8TH FLOOR C/O PEPGEN INC. BOSTON MA 02118 1 SVP, Clinical Development 1 Common Stock 2024-06-05 4 M 0 7245 10.21 A 7245 D Common Stock 2024-06-05 4 S 0 7245 18.09 D 0 D Common Stock 2024-06-06 4 M 0 1411 10.21 A 1411 D Common Stock 2024-06-06 4 S 0 1411 18.00 D 0 D Stock Option (Right to Buy) 10.21 2024-06-05 4 M 0 7245 0 D 2032-06-30 Common Stock 7245 92755 D Stock Option (Right to Buy) 10.21 2024-06-06 4 M 0 1411 0 D 2032-06-30 Common Stock 1411 91344 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This stock option vests over four years following the vesting commencement date (April 4, 2022) with 25% of such shares vesting on the first anniversary of the vesting commencement date, and the remaining shares vesting in 36 equal monthly installments, subject to continued service through each vesting date. /s/ Noel Donnelly, as Attorney-in-Fact 2024-06-07